Drug Type CAR-T |
Synonyms FACT 219, FACT219 |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Large B-cell lymphoma | Discovery | United States | 01 Jun 2025 | |
Rheumatic Diseases | Discovery | United States | 01 Jun 2025 |